Continuum Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $903K | Buy |
2,228
+182
| +9% | +$73.8K | 0.11% | 177 |
|
|
2025
Q1 | $1.02M | Sell |
2,046
-178
| -8% | -$88.6K | 0.13% | 149 |
|
|
2024
Q4 | $1.16M | Sell |
2,224
-10
| -0.4% | -$5.2K | 0.15% | 138 |
|
|
2024
Q3 | $1.19M | Sell |
2,234
-17
| -0.8% | -$9.06K | 0.15% | 144 |
|
|
2024
Q2 | $1.24M | Sell |
2,251
-6
| -0.3% | -$3.32K | 0.18% | 126 |
|
|
2024
Q1 | $1.3M | Sell |
2,257
-45
| -2% | -$26K | 0.2% | 119 |
|
|
2023
Q4 | $1.22M | Sell |
2,302
-203
| -8% | -$108K | 0.17% | 148 |
|
|
2023
Q3 | $1.27M | Sell |
2,505
-27
| -1% | -$13.7K | 0.2% | 137 |
|
|
2023
Q2 | $1.32M | Buy |
2,532
+1
| +0% | +$522 | 0.21% | 134 |
|
|
2023
Q1 | $1.46M | Sell |
2,531
-194
| -7% | -$112K | 0.25% | 116 |
|
|
2022
Q4 | $1.5M | Sell |
2,725
-142
| -5% | -$78.2K | 0.27% | 109 |
|
|
2022
Q3 | $1.45M | Buy |
2,867
+91
| +3% | +$46.2K | 0.26% | 102 |
|
|
2022
Q2 | $1.51M | Buy |
2,776
+32
| +1% | +$17.4K | 0.27% | 104 |
|
|
2022
Q1 | $1.52M | Buy |
2,744
+920
| +50% | +$509K | 0.29% | 97 |
|
|
2021
Q4 | $1.22M | Sell |
1,824
-59
| -3% | -$39.4K | 0.27% | 91 |
|
|
2021
Q3 | $1.08M | Buy |
1,883
+54
| +3% | +$30.9K | 0.29% | 91 |
|
|
2021
Q2 | $923K | Buy |
+1,829
| New | +$923K | 0.29% | 90 |
|
|
2018
Q1 | – | Sell |
-1,483
| Closed | -$282K | – | 173 |
|
|
2017
Q4 | $282K | Buy |
1,483
+80
| +6% | +$15.2K | 0.22% | 118 |
|
|
2017
Q3 | $265K | Buy |
1,403
+115
| +9% | +$21.7K | 0.23% | 118 |
|
|
2017
Q2 | $225K | Buy |
+1,288
| New | +$225K | 0.22% | 128 |
|